MPGLX
Price
$12.98
Change
+$0.08 (+0.62%)
Updated
Sep 8 closing price
Net Assets
44.82M
RGAGX
Price
$86.97
Change
+$0.48 (+0.55%)
Updated
Sep 8 closing price
Net Assets
332.38B
Interact to see
Advertisement

MPGLX vs RGAGX

Header iconMPGLX vs RGAGX Comparison
Open Charts MPGLX vs RGAGXBanner chart's image
MassMutual Disciplined Gr Adm
Price$12.98
Change+$0.08 (+0.62%)
VolumeN/A
Net Assets44.82M
American Funds Growth Fund of Amer R6
Price$86.97
Change+$0.48 (+0.55%)
VolumeN/A
Net Assets332.38B
MPGLX vs RGAGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MPGLX vs. RGAGX commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPGLX is a Buy and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 332B vs. MPGLX (44.8M). RGAGX pays higher dividends than MPGLX: RGAGX (0.59) vs MPGLX (0.00). MPGLX was incepted earlier than RGAGX: MPGLX (21 years) vs RGAGX (16 years). MPGLX (0.89) is less costly to investors than RGAGX (0.30). MPGLX is a more actively managed with annual turnover of: 69.00 vs. RGAGX (25.00). MPGLX has a lower initial minimum investment than RGAGX: MPGLX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 22.13 vs. MPGLX (12.40). RGAGX return over 5 years is better than : 46.68 vs. MPGLX (-0.96).
MPGLXRGAGXMPGLX / RGAGX
Total Expense Ratio0.890.30297%
Annual Report Gross Expense Ratio0.890.30297%
Fund Existence21 years16 years-
Gain YTD13.38616.66080%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets44.8M332B0%
Annual Yield % from dividends0.000.59-
Returns for 1 year12.4022.1356%
Returns for 3 years47.5354.3088%
Returns for 5 years-0.9646.68-2%
Returns for 10 years14.25103.9814%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOBX1.120.06
+5.66%
Mobix Labs
VSTA4.560.02
+0.44%
Vasta Platform Limited
TDACU10.40N/A
N/A
Translational Development Acquisition Corp
GRFS10.11-0.02
-0.20%
Grifols SA
BCRX8.19-0.08
-0.97%
BioCryst Pharmaceuticals